| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 08/19/2004 | US20040162287 Substituted cyclohexane-1,4-diamine compounds |
| 08/19/2004 | US20040162257 For inhibiting angiogenesis |
| 08/19/2004 | US20040162248 Preparation and diabetic use of gibberellins |
| 08/19/2004 | US20040161407 Medicinal compositions |
| 08/19/2004 | US20040161406 Use of interleukin-11 to treat gastrointestinal disorders |
| 08/19/2004 | DE10237722A1 Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase Indole or benzimidazole derivatives for the modulation of IkappaB kinase |
| 08/19/2004 | CA2694872A1 Improved thickened beverages for dysphagia |
| 08/19/2004 | CA2515717A1 Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient |
| 08/19/2004 | CA2514028A1 Substituted 2-aminoimidazoles, method for the production thereof, their use as a medicament or as a diagnostic reagent, and medicament containing these compounds |
| 08/18/2004 | EP1447405A1 Quinoline or quinazoline derivatives inhibiting auto-phosphorylation of fibroblast growth factor receptors |
| 08/18/2004 | EP1447401A1 Piperidin-2-one derivative compounds and drugs containing these compounds as the active ingredient |
| 08/18/2004 | EP1447400A1 Bicyclic compound |
| 08/18/2004 | EP1446874A2 Microphone-tailored equalizing system |
| 08/18/2004 | EP1446500A2 A method for regulating immune function in primates using the foxp3 protein |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |
| 08/18/2004 | EP1446417A2 Novel epidermal growth factor protein and gene, and methods of use therefor |
| 08/18/2004 | EP1446393A1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
| 08/18/2004 | EP1446392A1 Oligopeptides and compositions containing them as cathepsin s inhibitors |
| 08/18/2004 | EP1446385A1 Preparation and use of substituted imidazoles |
| 08/18/2004 | EP1446167A2 Treating canker sores with patches to speed healing and relieve pain |
| 08/18/2004 | EP1446155A1 Pharmaceutical composition comprising factor vii polypeptides and aprotinin polypeptides |
| 08/18/2004 | EP1446146A1 Pharmaceutical composition comprising factor vii polypeptides and pai-1 polypeptides |
| 08/18/2004 | EP1446136A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 08/18/2004 | EP1446129A2 Polynucleotide therapy |
| 08/18/2004 | EP1446125A1 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity |
| 08/18/2004 | EP1446115A2 Cyanoalkylamino derivatives as protease inhibitors |
| 08/18/2004 | EP1446113A2 Compounds and methods for treating transplant rejection |
| 08/18/2004 | EP1446110A2 Organosulfur inhibitors of tyrosine phosphatases |
| 08/18/2004 | EP1446106A2 Optimal polymer mixtures for gastric retentive tablets |
| 08/18/2004 | EP1446100A2 Injectable depot compositions and uses thereof |
| 08/18/2004 | EP1446088A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
| 08/18/2004 | EP1446023A1 Foodstuff |
| 08/18/2004 | EP1446015A1 Remodeling of tissues and organs |
| 08/18/2004 | EP1395273A4 Targeted delivery of drugs for the treatment of viral infections |
| 08/18/2004 | EP1315504B1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 08/18/2004 | EP1286997B1 6-phenylpyrrolopyrimidinedione derivatives |
| 08/18/2004 | EP1212309B1 Caspase inhibitor |
| 08/18/2004 | EP1187814B1 5-phenyl-pyrimidine derivatives |
| 08/18/2004 | EP1175397B1 3,3-substituted indoline derivatives |
| 08/18/2004 | EP1139789B1 Alpha-amylase-resistant starch for producing foodstuff and medicaments |
| 08/18/2004 | EP1134220B1 Benzoxazole derivatives and drugs containing the same as the active ingredient |
| 08/18/2004 | EP1086082B1 Arylsubstituted olefinic amines and their use as cholinergic receptors agonists |
| 08/18/2004 | EP0954330A4 Intestinal trefoil proteins |
| 08/18/2004 | EP0944599B1 Triarylethanes useful as pde iv inhibitors |
| 08/18/2004 | EP0820507B1 Ndf peptides |
| 08/18/2004 | CN1522258A Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines |
| 08/18/2004 | CN1522257A Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 08/18/2004 | CN1522252A Dihydro-benzo(b)(1,4)diazepin-2-one derivatives as mglur2 antagonists I |
| 08/18/2004 | CN1522241A Crystalline form of a phenylethanolamine, preparation thereof and pharmaceutical compositions comprising same |
| 08/18/2004 | CN1522159A Interferon formulations |
| 08/18/2004 | CN1522151A Modified fvii in treatment of ards |
| 08/18/2004 | CN1522149A Promoting whole body health |
| 08/18/2004 | CN1522147A Composition for treating drug-induced constipation with 15-keto-prostaglandins |
| 08/18/2004 | CN1521184A Hepatitis B virus pre-S mutain, and its preparing process and application |
| 08/18/2004 | CN1520878A Preparing process for nutrition and health oral liquid |
| 08/18/2004 | CN1520877A Preparing process for nutrition and health capsule |
| 08/18/2004 | CN1520869A Pharmaceutical for treating alimentary tract ulcer disease and preparing process thereof |
| 08/18/2004 | CN1520863A Formula and formulation of oral preparation for caring lung, maintaining appearance and invigorating the kidney using lily as main material |
| 08/18/2004 | CN1520860A Pharmaceutical composition for colitis |
| 08/18/2004 | CN1520856A Use of muskmelon plant extract in pharmacy |
| 08/18/2004 | CN1520851A Ulcerative stomatitis powder |
| 08/18/2004 | CN1520836A Pharmaceutical composition for treating hepatitis |
| 08/18/2004 | CN1520835A Liver cirrhosis and arteriosclerosis pharmaceutical composition |
| 08/18/2004 | CN1520834A Medical composition possessing function of refreshing oneself, senium-resistant, reinforcing body fluid and nourishing the blood, nourishing liver |
| 08/18/2004 | CN1520833A Composition for alcohol type fatty liver |
| 08/18/2004 | CN1520831A Health-preserving liver-protecting drug and method for making same |
| 08/18/2004 | CN1520824A Pharmaceutical use of asiaticoside |
| 08/18/2004 | CN1520815A Flavescent sophora root drop pills for treating hepatitis B |
| 08/18/2004 | CN1520810A Fatty liver therapeutic drug |
| 08/18/2004 | CN1162441C Pluraflavin and derivatives thereof, process for their preparation and use thereof |
| 08/18/2004 | CN1162432C 2,3-benzodiazepine derivatives |
| 08/18/2004 | CN1162177C Medicine for curing fatty liver |
| 08/18/2004 | CN1162168C Brain nourishing oral liquid and its preparing method |
| 08/17/2004 | US6777538 Binding protein |
| 08/17/2004 | US6777430 Phenylsulphonyl derivatives as 5-HT receptor ligands |
| 08/17/2004 | US6777409 For therapy of inflammation |
| 08/17/2004 | US6777408 Pyrido-thieno-diazepines method for the production thereof and pharmaceutical compositions containing said pyrido-thieno-diazepines |
| 08/17/2004 | US6777406 Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists |
| 08/17/2004 | US6777395 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase of hepatitis C virus |
| 08/17/2004 | US6776999 Expandable gastroretentive therapeutical system with prolonged stomach retention time |
| 08/17/2004 | CA2292921C Aryl carboxylic acid and tetrazole derivatives |
| 08/17/2004 | CA2258153C Hepatocyte growth factor receptor agonists and uses thereof |
| 08/17/2004 | CA2253980C Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof |
| 08/12/2004 | WO2004067729A1 Use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
| 08/12/2004 | WO2004067535A1 Thienopyrimidine compounds and use thereof |
| 08/12/2004 | WO2004067498A2 Aryl alkyl carbamate derivatives production and use thereof in therapy |
| 08/12/2004 | WO2004067093A2 Nk1 receptor antagonists for the treatment of functional dyspepsia |
| 08/12/2004 | WO2004067037A1 Intestinal environment controlling agent for oral use and normal intestinal flora growing kit for oral use |
| 08/12/2004 | WO2004067035A1 Use of avian antibodies |
| 08/12/2004 | WO2004067027A2 Osteogenic composition |
| 08/12/2004 | WO2004067024A2 Hcv combination therapy |
| 08/12/2004 | WO2004067008A1 Receptor agonists |
| 08/12/2004 | WO2004066998A1 Stable solid medicinal composition for oral administration |
| 08/12/2004 | WO2004066987A2 Use of sodium channel modulators for treating gastrointestinal tract disorders |
| 08/12/2004 | WO2004066909A2 Method for identifying novel treatments of inflammatory disease in the gut |
| 08/12/2004 | WO2004045718A3 Treatment of cognitive dysfunctions' |
| 08/12/2004 | WO2004026857A3 Methods of purifying cannabinoids from plant material |
| 08/12/2004 | WO2004022032A3 Pharmaceutical dosage form comprising a sulfite compound |
| 08/12/2004 | WO2003106444A8 N,n-disubstituted diazocycloalkanes useful for the treatment of cns disorders due to serotonergic dysfunction |
| 08/12/2004 | WO2003093231A3 Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity |